TIFFANY WADE: Open Payments
NPI 1033677885 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 54 payments from 14 companies in 2025. Trend: 2023 $971 · 2024 $1,204 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $201 |
| Lilly USA, LLC | 9 | $181 |
| AstraZeneca Pharmaceuticals LP | 6 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Biogen, Inc. | 1 | $113 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| ABBVIE INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 6 | $53 |
| Exact Sciences Corporation | 2 | $29 |
Products named: AIRSUPRA, ZURZUVAE, OFEV, Ozempic, KISUNLA, Auvelity, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
